Kisoji Biotechnology Inc.
Biotechnology
Overview
KisoJi Biotechnology. Breakthrough antibody discovery forbreakthrough therapeutics.
Funding and backers
Total raised
$41M
1 round on record
Latest round
$41M
Venture round · Dec 2024 · 23 mo ago
Team
11-50
employees, estimated range
Backers
1
Lumira Ventures
The money's age
Due for its next round
23 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 2, 2024
Raised a round Venture round $41M
Oct 24, 2024
Partnership Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic · PRNewswire
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2024 | $41M | — | news-journal.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…
Advanced Antibody Design Services. Macromoltek harnesses the power of computational modeling and artificial intelligence to accelerate and…
immunitoAI is an AI-driven biotechnology company accelerating antibody discovery and the development of antibody-based therapies through…
Panosome is developing a next-generation antibody discovery platform designed to accelerate the generation of diverse, high-quality…
星锐医药(Starna Therapeutics) 成立于2021年8月，公司聚焦肝外靶向递送技术，致力于研发以RNA为核心的创新药物，解决未被满足的临床需求。核心团队来自知名药企、高校和研究院所，团队拥有深厚的核酸药物发现、递送技术和制剂开发能力。.
A Novel Platform for Antibody Discovery, Engineering and Validation. Antibody therapies are an increasingly important tool for treating…
Financials
Total raised
$41M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $41M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Lumira VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic and Deploy AI Tools Into Key Pipeline Indications
KisoJi Biotechnology Inc., a company focused on the discovery and development of transformative antibody therapeutics, announces that it has raised $41 million in equity, including the conversion of previously funded convertible debentures. These funds wi
Read more
Report
KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic and Deploy AI Tools Into Key Pipeline Indications
Read more
Report
Cancer Research UK & KisoJi Biotechnology collaborate to advance the first naked antibody against TROP2 into clinical trial
Cancer Research UK & KisoJi Biotechnology collaborate to advance the first naked antibody against TROP2 into clinical trial
Read more
Report
Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic
/PRNewswire/ -- Cancer Research UK, one of the world
Read more
Report